|
1
|
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
|
Nat Cell Biol
|
2009
|
8.63
|
|
2
|
Impact of different crystalloid volume regimes on intestinal anastomotic stability.
|
Ann Surg
|
2009
|
1.95
|
|
3
|
The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
|
J Gastrointest Surg
|
2009
|
1.86
|
|
4
|
EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.
|
J Clin Oncol
|
2004
|
1.68
|
|
5
|
Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
|
J Cardiovasc Electrophysiol
|
2013
|
1.38
|
|
6
|
Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer.
|
Int J Cancer
|
2008
|
1.27
|
|
7
|
Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer.
|
Cancer Res
|
2009
|
1.18
|
|
8
|
Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1.
|
Diagn Pathol
|
2010
|
1.08
|
|
9
|
Increased expression of matrix metalloproteinase 2 in uterosacral ligaments is associated with pelvic organ prolapse.
|
Int Urogynecol J Pelvic Floor Dysfunct
|
2005
|
1.06
|
|
10
|
Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases.
|
Am J Surg Pathol
|
2006
|
1.03
|
|
11
|
Weak expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome.
|
Clin Cancer Res
|
2006
|
0.98
|
|
12
|
The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice.
|
Arterioscler Thromb Vasc Biol
|
2011
|
0.97
|
|
13
|
Atypical cyst formation following chin augmentation using a nasal osteocartilaginous graft.
|
J Craniomaxillofac Surg
|
2006
|
0.92
|
|
14
|
Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver.
|
Virus Res
|
2009
|
0.91
|
|
15
|
Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway.
|
Am J Pathol
|
2002
|
0.90
|
|
16
|
A rapid and reliable enzyme immunoassay PCR-based screening method to identify EBV-carrying gastric carcinomas.
|
Mod Pathol
|
2002
|
0.88
|
|
17
|
Expression levels of hnRNP G and hTra2-beta1 correlate with opposite outcomes in endometrial cancer biology.
|
Int J Cancer
|
2011
|
0.86
|
|
18
|
Expression of the transcriptional coregulator FHL2 in human breast cancer: a clinicopathologic study.
|
J Soc Gynecol Investig
|
2006
|
0.86
|
|
19
|
Chemotherapy, liver injury, and postoperative complications in colorectal liver metastases.
|
J Gastrointest Surg
|
2011
|
0.86
|
|
20
|
IL-1B promoter polymorphism and Epstein-Barr virus in Dutch patients with gastric carcinoma.
|
Int J Cancer
|
2003
|
0.86
|
|
21
|
Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBV-associated gastric cancer.
|
Virchows Arch
|
2008
|
0.84
|
|
22
|
Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients.
|
J Cancer Res Clin Oncol
|
2008
|
0.83
|
|
23
|
Colloid vs. crystalloid infusions in gastrointestinal surgery and their different impact on the healing of intestinal anastomoses.
|
Int J Colorectal Dis
|
2009
|
0.83
|
|
24
|
Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.
|
BMC Cancer
|
2013
|
0.82
|
|
25
|
Alternative splicing-related factor YT521: an independent prognostic factor in endometrial cancer.
|
Int J Gynecol Cancer
|
2010
|
0.81
|
|
26
|
Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer.
|
Breast Cancer Res Treat
|
2009
|
0.81
|
|
27
|
Fluorescence in situ hybridization confirms the presence of Merkel cell polyomavirus in chronic lymphocytic leukemia cells.
|
Blood
|
2011
|
0.81
|
|
28
|
EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
|
Cell Oncol (Dordr)
|
2011
|
0.80
|
|
29
|
Magnetization transfer ratio: a potential biomarker for the assessment of postradiation fibrosis in patients with rectal cancer.
|
Invest Radiol
|
2014
|
0.80
|
|
30
|
Nucleoporin 88 expression in hepatitis B and C virus-related liver diseases.
|
World J Gastroenterol
|
2006
|
0.79
|
|
31
|
Microarray-based amplification and detection of RNA by nucleic acid sequence based amplification.
|
Anal Bioanal Chem
|
2010
|
0.79
|
|
32
|
Ischemic preconditioning improves stability of intestinal anastomoses in rats.
|
Int J Colorectal Dis
|
2009
|
0.79
|
|
33
|
Fluorescence in situ hybridization and qPCR to detect Merkel cell polyomavirus physical status and load in Merkel cell carcinomas.
|
Int J Cancer
|
2014
|
0.79
|
|
34
|
Expression of focal adhesion kinase in patients with endometrial cancer: a clinicopathologic study.
|
Int J Gynecol Cancer
|
2009
|
0.78
|
|
35
|
Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes.
|
Med Microbiol Immunol
|
2005
|
0.78
|
|
36
|
Detection of lymph node involvement by cytokeratin immunohistochemistry is an independent prognostic factor after curative resection of esophageal cancer.
|
J Gastrointest Surg
|
2010
|
0.77
|
|
37
|
A polymer-based DNA biochip platform for human papilloma virus genotyping.
|
J Virol Methods
|
2009
|
0.76
|
|
38
|
BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article.
|
Medicine (Baltimore)
|
2014
|
0.76
|
|
39
|
Esophageal (Barrett's) adenocarcinoma is not associated with Epstein-Barr virus infection: an analysis of 162 cases.
|
Int J Cancer
|
2005
|
0.76
|
|
40
|
Nucleic acid sequence-based amplification in formalin-fixed and paraffin-embedded breast-cancer tissues.
|
J Clin Pathol
|
2010
|
0.75
|